← Browse by Condition
Medical Condition
von willebrand disease type 3
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
ClinicalMetric aggregates all active clinical trials for von willebrand disease type 3 from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.
- Recruiting trials — currently enrolling participants, with eligibility criteria
- Phase 1–4 studies — from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary for every trial listing
NCT06998524 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
Enrollment
75 pts
Location
United States, Belgi...
Sponsor
Hoffmann-La Roche
NCT06883240
Recruiting
An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
Enrollment
40 pts
Location
United States, Belgi...
Sponsor
Hoffmann-La Roche